Isabelle Beau
Research Subjects
Research Interests
Isabelle Beau has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ashish Jain
Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
1 shared publication Lionel Larue
Institut Curie Orsay, France
1 shared publicationMatthieu Bertrand
A INSERM UMRS984 Châtenay-Malabry , France
1 shared publication- Patrice Codogno
Institut Necker Enfants-Malades (INEM), INSERM U1151/CNRS UMR 8253, Université de Paris, Paris, France
1 shared publication Raymonde Amsellem
INSERM UMRS984 Châtenay-Malabry, France
1 shared publication- Terje Johansen
Autophagy Research Group, Department of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway
1 shared publication
Latest Publications
- 1 February 2015
- Published by Taylor & Francis in Cell Cycle
- Vol. 14 (3) , 364-374
SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors
The epithelial to mesenchymal transition (EMT) is an essential process during development and during tumor progression. Here, we observed the accumulation of the selective autophagy receptor and signaling adaptor sequestosome-1 (SQSTM1/p62) during growth factor-induced EMT in immortalized and tumor-derived epithelial cell lines. Modulation of the p62 level regulated the expression of junctional proteins. This effect was dependent on the ubiquitin-associated domain of p62, which stabilized the TGFβ/Smad signaling co-activator Smad4 and the EMT transcription factor Twist. This study highlights a novel function of p62 in a major epithelial phenotypic alteration.
- 1 February 2015
- Published by Taylor & Francis in Cell Cycle
- Vol. 14 (3) , 364-374
SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors
The epithelial to mesenchymal transition (EMT) is an essential process during development and during tumor progression. Here, we observed the accumulation of the selective autophagy receptor and signaling adaptor sequestosome-1 (SQSTM1/p62) during growth factor-induced EMT in immortalized and tumor-derived epithelial cell lines. Modulation of the p62 level regulated the expression of junctional proteins. This effect was dependent on the ubiquitin-associated domain of p62, which stabilized the TGFβ/Smad signaling co-activator Smad4 and the EMT transcription factor Twist. This study highlights a novel function of p62 in a major epithelial phenotypic alteration.